Mouse Anti-Human CR2 Monoclonal Antibody (CTJS-320)(Cat#: CTA-150)

This product is an unconjugated anti-Human CR2 Monoclonal antibody (CTJS-320) generated from the Mouse. The antibody can be used for WB; FC.

Summary Related Products & Services

Specifications
Clonality Monoclonal
Clone CTJS-320
Host Animal Mouse
Isotype IgG1
Immunogen Chinese hamster ovary cell line CHO-derived recombinant human CD21
Ile21-Arg971
Species Reactivity Human
Applications WB; FC
Application Notes WB: 2 µg/mL
FC: 0.25 ug/10^6 cells
The optimal working dilutions should be determined by the end user.
Specificity This antibody reacts with Human CR2.
Purity ≥95% as determined by SDS-PAGE
Format Lyophilized
Size 25; 100 µg
Storage 12 months from date of receipt, -20 to -70 °C as supplied.
1 month, 2 to 8 °C under sterile conditions after reconstitution.
6 months, -20 to -70 °C under sterile conditions after reconstitution.Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
Type Primary Antibody
Target
Target Name CR2
Alternative Names Complement C3d Receptor 2; Complement Component (3d/Epstein Barr Virus) Receptor 2; Complement Component 3d Receptor 2; Epstein-Barr Virus Receptor; EBV Receptor; Complement C3d Receptor; CD21 Antigen; Cr2; CR; C3DR; CD21; CVID7; SLEB9
Gene ID 1380
UniProt ID P20023
Information
Introduction omplement receptor type 2 (CR2), also known as complement C3d receptor, Epstein-Barr virus receptor, and CD21 (cluster of differentiation 21), is a protein that in humans is encoded by the CR2 gene. CR2 is involved in the complement system. It binds to iC3b (inactive derivative of C3b), C3dg, or C3d. B cells have CR2 receptors on their surfaces, allowing the complement system to play a role in B-cell activation and maturation. it is receptor for complement C3Dd, for the Epstein-Barr virus on human B-cells and T-cells and for HNRNPU, and participates in B lymphocytes activation.
For Research Use Only. Not for Diagnostic or Therapeutic Applications.
Online Inquiry